IFNgamma/JAK/STAT1/CD38 pathway in SH2D1Bhigh NK cells: Implications for inflammation in type 1 diabetes. Chen J, Fu L, Gong Y, Liao L, et al. J Immunol 2026;215:vkaf347.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen J, Fu L, Gong Y, Liao L, et al. IFNgamma/JAK/STAT1/CD38 pathway in SH2D1Bhigh NK cells: Implications for inflammation in type 1 diabetes. J Immunol 2026;215:vkaf347.
PMID: 41764744